DE69009715D1 - Azabicycloamide und -ester als 5-HT3-Receptor-Antagonisten. - Google Patents

Azabicycloamide und -ester als 5-HT3-Receptor-Antagonisten.

Info

Publication number
DE69009715D1
DE69009715D1 DE69009715T DE69009715T DE69009715D1 DE 69009715 D1 DE69009715 D1 DE 69009715D1 DE 69009715 T DE69009715 T DE 69009715T DE 69009715 T DE69009715 T DE 69009715T DE 69009715 D1 DE69009715 D1 DE 69009715D1
Authority
DE
Germany
Prior art keywords
esters
azabicycloamides
receptor antagonists
antagonists
receptor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69009715T
Other languages
English (en)
Other versions
DE69009715T2 (de
Inventor
Terry Jay Rosen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Publication of DE69009715D1 publication Critical patent/DE69009715D1/de
Application granted granted Critical
Publication of DE69009715T2 publication Critical patent/DE69009715T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Otolaryngology (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE69009715T 1989-11-17 1990-11-08 Azabicycloamide und -ester als 5-HT3-Receptor-Antagonisten. Expired - Fee Related DE69009715T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1989/005097 WO1991007402A1 (en) 1989-11-17 1989-11-17 Azabicyclo amides and esters as 5-ht3 receptor antagonists

Publications (2)

Publication Number Publication Date
DE69009715D1 true DE69009715D1 (de) 1994-07-14
DE69009715T2 DE69009715T2 (de) 1994-09-22

Family

ID=22215354

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69009715T Expired - Fee Related DE69009715T2 (de) 1989-11-17 1990-11-08 Azabicycloamide und -ester als 5-HT3-Receptor-Antagonisten.

Country Status (11)

Country Link
EP (1) EP0434202B1 (de)
JP (1) JPH0699428B2 (de)
AT (1) ATE106886T1 (de)
CA (1) CA2030077C (de)
DE (1) DE69009715T2 (de)
DK (1) DK0434202T3 (de)
ES (1) ES2055344T3 (de)
FI (1) FI922124A0 (de)
IE (1) IE63420B1 (de)
PT (1) PT95895A (de)
WO (1) WO1991007402A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9027111D0 (en) * 1990-12-13 1991-02-06 Raychem Ltd Circuit protection device
GB9214184D0 (en) * 1992-07-03 1992-08-12 Smithkline Beecham Plc Pharmaceuticals
FR2699533A1 (fr) * 1992-12-21 1994-06-24 Mouhtaram Mohamed Dérivés de N-((1,4-dialkyl-6-arylpipérazine-2-yl)méthyl)benzamides. (Isomères cis et trans) Propriétés pharmacologiques et applications.
EP1828179B1 (de) * 2004-12-22 2010-01-20 Memory Pharmaceuticals Corporation Nikotinische alpha-7-rezeptorliganden gegen erkrankungen des zns

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3405134A (en) * 1965-08-17 1968-10-08 Colgate Palmolive Co Quinuclidyl esters of aromatic acids
US4467095A (en) * 1969-02-10 1984-08-21 Fmc Corporation Anticholinergic compounds
US3563995A (en) * 1969-04-17 1971-02-16 Ian Wellings Alkyl esters of 1-azabicyclo(2.2.2)oct-2-ene-3-(4 - chloro-3-sulfamoylanilino)-2-carboxylic acid
GB1293446A (en) * 1970-07-23 1972-10-18 Rech S Et D Applic Scient Soge Quinuclidine derivatives, the preparation thereof and pharmaceutical compositions containing them
FR2531955A1 (fr) * 1982-08-17 1984-02-24 Pharmuka Lab Nouveau procede de preparation de derives de la quinuclidine substitues en position 3
CH667657A5 (de) * 1985-01-07 1988-10-31 Sandoz Ag Carbocyclische und heterocyclische carbonylmethylen- und methylpiperidine und -pyrrolidine.
GB8525844D0 (en) * 1985-10-19 1985-11-20 Beecham Group Plc Compounds
EP0311724A1 (de) * 1987-10-16 1989-04-19 Synthelabo Anxiolytische R-N-(1-Azabicyclo[2.2.2]oct-3-yl)-benzamide und -thiobenzamide

Also Published As

Publication number Publication date
PT95895A (pt) 1991-09-13
IE904134A1 (en) 1991-05-22
EP0434202B1 (de) 1994-06-08
ES2055344T3 (es) 1994-08-16
EP0434202A1 (de) 1991-06-26
WO1991007402A1 (en) 1991-05-30
IE63420B1 (en) 1995-04-19
DE69009715T2 (de) 1994-09-22
FI922124A (fi) 1992-05-11
FI922124A0 (fi) 1992-05-11
JPH03170480A (ja) 1991-07-24
JPH0699428B2 (ja) 1994-12-07
CA2030077A1 (en) 1991-05-18
ATE106886T1 (de) 1994-06-15
DK0434202T3 (da) 1994-07-04
CA2030077C (en) 1995-08-22

Similar Documents

Publication Publication Date Title
DE69127791D1 (de) Diazabicyclononyl-Derivate als 5-HT3 Rezeptor Antagonisten
SE8303651L (sv) Bensoesyrapiperidylesterderivat
FI921345A (fi) Piperidinderivat
DE3476204D1 (de) N-(bicyclic heterocyclyl)-4-piperidinamines
PL316658A1 (en) Novel application of serotonin antagonists
DE69207351T2 (de) Fibrinogen-Rezeptor-Antagoniste
MX9101311A (es) Antagonistas receptores de fibrinogeno
DE69431604D1 (de) Benzofuranderivate als tachykininantagonisten
NO844755L (no) Bicykliske heterocyklyholdige n-(bicykliske heterocyklyl)-4-piperidinaminer
DE69425655T2 (de) Antagonisten des fibrinogenrezeptors
DE69012867T2 (de) Direktanlernbarer Roboter.
DE69022553T2 (de) Vorrichtung zum Unterdrücken von Spannungsschwankungen und Oberschwingungen.
DE69426452D1 (de) Fibrinogen receptor antagonisten
FI945000A0 (fi) Menetelmä (S)-amino-1-substituoitujen pyrrolidiinien valmistamiseksi
DE69009715D1 (de) Azabicycloamide und -ester als 5-HT3-Receptor-Antagonisten.
FI891473A (fi) Menetelmä terapeuttisesti käyttökelpoisten 4-aryyli-4-piperidiinikarbinolien valmistamiseksi
DE69328701T2 (de) Diazabicycloderivate als 5-HT3-Antagonisten
FI913835A0 (fi) 6-substituerade-tetrahydrobenz(cd) indoler.
FI892051A (fi) Foerfarande foer framstaellning av 5-klor-3-klorsulfonyl-2-tiofencarbonsyraestrar.
DE69023747T3 (de) Verwendung von Aminoxiden als antistatischen Agenzien.
IT9083326A0 (it) Attrezzo per sviluppare le capacita' psico-motorie del bambino
LV10425A (lv) Fibrinogena receptoru antagonisti
KR950004751U (ko) 모니터의 화면 마아킹 치구
IE881220L (en) 5-ht3 receptor antagonists
DE69308680D1 (de) Gebrauch von Oxatomide als Antitussivum

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee